A detailed history of Principal Securities, Inc. transactions in Insulet Corp stock. As of the latest transaction made, Principal Securities, Inc. holds 412 shares of PODD stock, worth $117,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
412
Previous 382 7.85%
Holding current value
$117,296
Previous $88.9 Million 20.98%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$227.79 - $275.7 $6,833 - $8,271
30 Added 7.85%
412 $108 Million
Q3 2024

Oct 28, 2024

SELL
$180.69 - $239.01 $22,405 - $29,637
-124 Reduced 24.51%
382 $88.9 Million
Q2 2024

Jul 31, 2024

BUY
$161.02 - $206.98 $39,449 - $50,710
245 Added 93.87%
506 $102 Million
Q1 2024

May 10, 2024

SELL
$163.6 - $209.11 $9,488 - $12,128
-58 Reduced 18.18%
261 $44.7 Million
Q4 2023

Feb 07, 2024

BUY
$127.77 - $221.42 $40,758 - $70,632
319 New
319 $69.2 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $19.8B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.